Patents by Inventor Laura E. Pope

Laura E. Pope has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITIONS COMPRISING DEXTROMETHORPHAN AND QUINIDINE FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
    Publication number: 20200276185
    Abstract: Pharmaceutical compositions and methods for treating neurological disorders by administering same are provided. The compositions comprise dextromethorphan in combination with quinidine.
    Type: Application
    Filed: October 3, 2019
    Publication date: September 3, 2020
    Inventors: Gerald Yakatan, James Berg, Laura E. Pope, Richard A. Smith
  • PHARMACEUTICAL COMPOSITIONS COMPRISING DEXTROMETHORPHAN AND QUINIDINE FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
    Publication number: 20190201391
    Abstract: Pharmaceutical compositions and methods for treating neurological disorders by administering same are provided. The compositions comprise dextromethorphan in combination with quinidine.
    Type: Application
    Filed: July 26, 2018
    Publication date: July 4, 2019
    Inventors: Gerald YAKATAN, James BERG, Laura E. POPE, Richard A. SMITH
  • PHARMACEUTICAL COMPOSITIONS COMPRISING DEXTROMETHORPHAN AND QUINIDINE FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
    Publication number: 20180098984
    Abstract: Pharmaceutical compositions and methods for treating neurological disorders by administering same are provided. The compositions comprise dextromethorphan in combination with quinidine.
    Type: Application
    Filed: May 22, 2017
    Publication date: April 12, 2018
    Inventors: Gerald YAKATAN, James BERG, Laura E. POPE, Richard A. SMITH
  • PHARMACEUTICAL COMPOSITIONS COMPRISING DEXTROMETHORPHAN AND QUINIDINE FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
    Publication number: 20160287576
    Abstract: Pharmaceutical compositions and methods for treating neurological disorders by administering same are provided. The compositions comprise dextromethorphan in combination with quinidine.
    Type: Application
    Filed: April 6, 2016
    Publication date: October 6, 2016
    Inventors: Gerald Yakatan, James Berg, Laura E. Pope, Richard A. Smith
  • PHARMACEUTICAL COMPOSITIONS COMPRISING DEXTROMETHORPHAN AND QUINIDINE FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
    Publication number: 20150209347
    Abstract: Pharmaceutical compositions and methods for treating neurological disorders by administering same are provided. The compositions comprise dextromethorphan in combination with quinidine.
    Type: Application
    Filed: April 7, 2015
    Publication date: July 30, 2015
    Inventors: Gerald Yakatan, James Berg, Laura E. Pope, Richard A. Smith
  • PHARMACEUTICAL COMPOSITIONS COMPRISING DEXTROMETHORPHAN AND QUINIDINE FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
    Publication number: 20140288114
    Abstract: Pharmaceutical compositions and methods for treating neurological disorders by administering same are provided. The compositions comprise dextromethorphan in combination with quinidine.
    Type: Application
    Filed: June 6, 2014
    Publication date: September 25, 2014
    Inventors: Gerald Yakatan, James Berg, Laura E. Pope, Richard A. Smith
  • PHARMACEUTICAL COMPOSITIONS COMPRISING DEXTROMETHORPHAN AND QUINIDINE FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
    Publication number: 20140045880
    Abstract: Pharmaceutical compositions and methods for treating neurological disorders by administering same are provided. The compositions comprise dextromethorphan in combination with quinidine.
    Type: Application
    Filed: October 21, 2013
    Publication date: February 13, 2014
    Applicant: Avanir Pharmaceuticals, Inc.
    Inventors: Gerald Yakatan, James Berg, Laura E. Pope, Richard A. Smith
  • Pharmaceutical Compositions Comprising Dextromethorphan and Quinidine for the Treatment of Neurological Disorders
    Publication number: 20120165363
    Abstract: Pharmaceutical compositions and methods for treating neurological disorders by administering same are provided. The compositions comprise dextromethorphan in combination with quinidine.
    Type: Application
    Filed: March 8, 2012
    Publication date: June 28, 2012
    Applicant: AVANIR PHARMACEUTICALS, INC.
    Inventors: Gerald YAKATAN, James Berg, Laura E. Pope, Richard A. Smith
  • PHARMACEUTICAL COMPOSITIONS COMPRISING DEXTROMETHORPHAN AND QUINIDINE FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
    Publication number: 20100137352
    Abstract: Pharmaceutical compositions and methods for treating neurological disorders by administering same are provided. The compositions comprise dextromethorphan in combination with quinidine.
    Type: Application
    Filed: February 3, 2010
    Publication date: June 3, 2010
    Applicant: AVANIR PHARMACEUTICALS, INC.
    Inventors: Gerald YAKATAN, James Berg, Laura E. Pope, Richard A. Smith
  • Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
    Patent number: 7659282
    Abstract: Pharmaceutical compositions and methods for treating neurological disorders by administering same are provided. The compositions comprise dextromethorphan in combination with quinidine.
    Type: Grant
    Filed: January 12, 2005
    Date of Patent: February 9, 2010
    Assignee: Avanir Pharmaceuticals, Inc.
    Inventors: Gerald Yakatan, James Berg, Laura E. Pope, Richard A. Smith
  • PHARMACEUTICAL COMPOSITIONS COMPRISING DEXTROMETHORPHAN AND QUINIDINE FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
    Publication number: 20090082384
    Abstract: Pharmaceutical compositions and methods for treating neurological disorders by administering same are provided. The compositions comprise dextromethorphan in combination with quinidine.
    Type: Application
    Filed: November 25, 2008
    Publication date: March 26, 2009
    Applicant: Avanir Pharmaceuticals
    Inventors: Gerald Yakatan, James Berg, Laura E. Pope, Richard A. Smith
  • Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
    Patent number: 7091190
    Abstract: The present invention is related to antiviral compositions comprising long-chain aliphatic compounds in combination with a nucleoside analog or phosphonoformic acid, in a pharmaceutically acceptable carrier. Methods for treating viral infections using such compositions are also disclosed.
    Type: Grant
    Filed: July 16, 2002
    Date of Patent: August 15, 2006
    Assignee: Avanir Pharmaceuticals
    Inventors: John F. Marcelletti, Laura E. Pope, Mohammed H. Khalil, David H. Katz, Lee R. Katz
  • Viral inhibition by n-docosanol
    Publication number: 20040033982
    Abstract: This invention relates to topical therapeutic preparations and methods for treating viral and inflammatory diseases and for reducing the pain of topical inflammation of skin and mucous membranes. The preparations include creams containing n-docosanol.
    Type: Application
    Filed: December 20, 2002
    Publication date: February 19, 2004
    Inventors: David H Katz, Mohammed H Khalil, Laura E Pope, John F Marcelletti
  • Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
    Publication number: 20030073651
    Abstract: The present invention is related to antiviral compositions comprising long-chain aliphatic compounds in combination with a nucleoside analog or phosphonoformic acid, in a pharmaceutically acceptable carrier. Methods for treating viral infections using such compositions are also disclosed.
    Type: Application
    Filed: July 16, 2002
    Publication date: April 17, 2003
    Inventors: John F. Marcelletti, Laura E. Pope, Mohammed H. Khalil, David H. Katz, Lee R. Katz
  • Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
    Patent number: 6440980
    Abstract: The present invention is related to antiviral compositions comprising long-chain aliphatic compounds in combination with a nucleoside analog or phosphonoformic acid, in a pharmaceutically acceptable carrier. Methods for treating viral infections using such compositions are also disclosed.
    Type: Grant
    Filed: March 10, 1999
    Date of Patent: August 27, 2002
    Assignee: Avanir Pharmaceuticals
    Inventors: John F. Marcelletti, Laura E. Pope, Mohammed H. Khalil, David H. Katz, Lee R. Katz
  • Treatment of hyperproliferative skin disorders with C18 to C20 aliphatic alcohols
    Patent number: 6313179
    Abstract: A method is disclosed for treating a benign or malignant hyperproliferative skin lesion, comprising topically administering a C18 to C20 aliphatic alcohol to the skin lesion in a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: December 11, 1998
    Date of Patent: November 6, 2001
    Assignee: Avanir Pharmaceuticals
    Inventors: Laura E. Pope, Mohammed H. Khalil, John F. Marcelletti, Lee R. Katz, David H. Katz
  • Long-chain alcohols, alkanes, fatty acids and amides in the treatment of burns and viral inhibition
    Patent number: 5952392
    Abstract: Therapeutic compositions including a nonionic surfactant combined with long chain fatty acids, alkanes, amides or mono-unsaturated alcohols, particularly stearyl alcohol, erucyl alcohol, brassidyl alcohol, arachidyl alcohol, n-docosane, n-docosanoic acid, erucamide and stearic acid, or mixtures thereof, as active ingredients are disclosed. Methods of preventing or treating viral infections, treating skin or membrane inflammation or inhibiting cell proliferation using such compositions are disclosed.
    Type: Grant
    Filed: August 22, 1997
    Date of Patent: September 14, 1999
    Assignee: Avanir Pharmaceuticals
    Inventors: David H. Katz, Laura E. Pope, Mohammed H. Khalil, John F. Marcelletti, Lee R. Katz
  • Treatment of hyperproliferative skin disorders with C18 to C26 alphatic alcohols
    Patent number: 5948822
    Abstract: A method for treating a benign or malignant hyperproliferative skin lesion, comprising topically administering a C18 to C26 aliphatic alcohol to the skin lesion in a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: November 25, 1997
    Date of Patent: September 7, 1999
    Assignee: Lidak Pharmaceuticals
    Inventors: Laura E. Pope, Mohammed H. Khalil, John F. Marcelletti, Lee R. Katz, David H. Katz
  • Sucrose ester-C20 to C28 alcohol formulations
    Patent number: 5534554
    Abstract: A stable, efficacious therapeutic cream wherein a principal therapeutic compounds are one or more C-20 to C-28 long chain aliphatic alcohols, of which n-docosanol is exemplary, comprising sucrose cocoate, sucrose stearates or sucrose distearate, or mixtures thereof, is disclosed.
    Type: Grant
    Filed: September 2, 1994
    Date of Patent: July 9, 1996
    Assignee: Lidak Pharmaceuticals
    Inventors: David H. Katz, Mohammed H. Khalil, John F. Marcelletti, Laura E. Pope, Lee R. Katz